Apr. 14 at 8:06 PM
$KMTS Kestra Medical reports Q3 EPS (
$1.25) vs. (
$1.18) last year
Reports Q3 revenue
$15.09M vs.
$8.28M last year. "Our quarterly results reflect sustained commercial momentum as Kestra grows and penetrates the wearable defibrillator market," said Brian Webster, president and CEO. "We continue to make progress on our key operational objectives, including expansion of our commercial organization and advancement of our revenue cycle management capabilities. Following our initial public offering in March, we remain focused on delivering strong growth and executing on our commitments to patients and their prescribers."